SCHEMBL15416670

SCHEMBL15416670

O=CC(N1CCCC1)n1cnc2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.44
MEN1 O00255 1/20 0.44
HPGD P15428 1/20 0.44
KMT2A Q03164 1/20 0.44
GAA P10253 1/20 0.40
HDAC8 Q9BY41 1/20 0.39
FGFR1 P11362 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HTT P42858 4/20 0.36
ADRA2A P08913 1/20 0.36
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
GGPS1 O95749 1/20 0.35
FDPS P14324 1/20 0.35
P2RX7 Q99572 1/20 0.34
KCNA5 P22460 3/20 0.34
KCNE1 P15382 1/20 0.34
APAF1 O14727 1/20 0.34
DNMT3A Q9Y6K1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27341190 0.73 MEN1 (0.58) HSD17B10MEN1HPGDKMT2AHDAC8
SCHEMBL5033557 0.70 FDPS (0.36) FDPS
SCHEMBL15416404 0.70 HDAC8 (0.46) HSD17B10MEN1HPGDKMT2AGAA
SCHEMBL14638103 0.67 MEN1 (0.64) HSD17B10MEN1HPGDKMT2AHDAC8
SCHEMBL9754107 0.67 HSD17B10 (0.54) HSD17B10MEN1HPGDKMT2AHDAC8
SCHEMBL12419715 0.67 MEN1 (0.54) HSD17B10MEN1HPGDKMT2AHDAC8
SCHEMBL15416402 0.67 HTT (0.50) HSD17B10MEN1HPGDKMT2AGAA
SCHEMBL1027011 0.67 HPGD (0.68) HSD17B10MEN1HPGDKMT2AGAA
SCHEMBL2146965 0.67 MEN1 (0.68) HSD17B10MEN1HPGDKMT2AHDAC8
SCHEMBL4785512 0.67 MEN1 (0.58) HSD17B10MEN1HPGDKMT2AHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2872502-A1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2015-05-20 EP disclosed
WO-2014009302-A1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2014-01-16 WO disclosed